New Federal Privacy Rules Stump Researchers

A new federal rule designed to protect patients' privacy rights could handicap researchers and prompt legal challenges, according to health policy experts. The privacy rule in the Health Insurance Portability and Accountability Act of 1996 (HIPAA)--for which the Department of Health and Human Services released guidelines in July--requires that researchers who use the nation's tissue banks obtain authorizations when they use patient-specific information, such as medical histories. According to HI

Written byKatherine Uraneck
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

"The rule will have substantial effects on conduct of medical and health sciences research," says David Korn, senior vice president of biomedical and health sciences research for the Association of Academic Medical Centers. "The effect of some of its provisions will, we fear, be most unfortunate." Korn, a research pathologist and past dean of Stanford Medical School, is particularly concerned that the enormous archives of human-tissue samples in the nation's hospitals and academic medical centers may be at risk. These banked tissues have become an increasingly valuable resource with the introduction of new techniques such as the use of monoclonal antibodies and PCR.

Courtesy of Davis Wwright Tremain LLP

Carol Pratt

Historically, human tissue samples removed for medical reasons are archived with a standard consent form that grants permission to use the tissue for any research in the future. "This is no longer valid," says Carol Pratt, health care attorney who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies